Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.
Sahuquillo-Torralba A, Mansilla-Polo M, Pujol-Marco C, Llamas-Velasco M, Rull EV, Ruiz Villaverde R, Ferran M, Pitarch G, Lopez A, Beltran E, Urruticoechea-Arana A, Riera-Monroig J, Alsina M, Vidal D, Belinchón Romero I, Notario J, Carrascosa JM, Gonzalez-Delgado V, Mollet J, Ribera M, Gallardo F. Sahuquillo-Torralba A, et al. Int J Dermatol. 2024 May 12. doi: 10.1111/ijd.17238. Online ahead of print. Int J Dermatol. 2024. PMID: 38736107
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.
Martorell A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran-Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Martorell A, et al. Among authors: sahuquillo torralba a. Actas Dermosifiliogr. 2024 Mar 6:S0001-7310(24)00187-X. doi: 10.1016/j.ad.2024.02.030. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 38452889 English, Spanish.
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Daudén E, Escario E, Martos-Cabrera L, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera R, de la Cueva P, Martorell A, Ballesca F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés O, Feltes R, Riera-Monroig J, Garrido J, Llamas-Velasco M. Daudén E, et al. Among authors: sahuquillo torralba a. Int J Dermatol. 2024 Apr;63(4):503-511. doi: 10.1111/ijd.16915. Epub 2024 Jan 2. Int J Dermatol. 2024. PMID: 38168847
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.
Muñoz-Aceituno E, Butrón-Bris B, Ovejero-Benito MC, Sahuquillo-Torralba A, Baniandrés Rodríguez O, Herrera-Acosta E, Rivera-Diaz R, Ferran M, Sánchez-Carazo JL, Riera-Monroig J, Pujol-Montcusí J, Vidal D, de la Cueva P, García-Bustinduy M, Ruiz-Villaverde R, Ballescà F, Llamas-Velasco M, Navares M, Palomar-Moreno I, Sánchez-García I, García-Martínez J, Novalbos J, Zubiaur P, Abad-Santos F, Daudén-Tello E, de la Fuente H. Muñoz-Aceituno E, et al. Among authors: sahuquillo torralba a. J Eur Acad Dermatol Venereol. 2023 Dec 28. doi: 10.1111/jdv.19782. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 38153843
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Lluch-Galcerá JJ, Carrascosa JM, González-Quesada A, Rivera-Díaz R, Sahuquillo-Torralba A, Llamas-Velasco M, Gómez-García FJ, Herrera-Acosta E, de la Cueva P, Baniandrés-Rodríguez O, Lopez-Estebaranz JL, Belinchón I, Ferrán M, Mateu A, Rodríguez L, Riera-Monroig J, Abalde-Pintos MT, Carretero G, García-Donoso C, Pujol-Marco C, Del Alcázar E, Santamaría-Domínguez C, Suárez-Pérez JA, Nieto-Benito LM, Ruiz-Genao DP, Salgado-Boquete L, Descalzo MÁ, García-Doval I. Lluch-Galcerá JJ, et al. Among authors: sahuquillo torralba a. Br J Dermatol. 2024 Feb 16;190(3):355-363. doi: 10.1093/bjd/ljad382. Br J Dermatol. 2024. PMID: 37846976
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice.
Reymundo A, Armesto S, Rodríguez L, Baniandrés O, Sahuquillo-Torralba A, Torres T, de la Cueva P, Llamas-Velasco M, Daudén E. Reymundo A, et al. Among authors: sahuquillo torralba a. J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1480-e1482. doi: 10.1111/jdv.19371. Epub 2023 Aug 7. J Eur Acad Dermatol Venereol. 2023. PMID: 37471473 No abstract available.
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.
Phan DB, Jourdain H, González-Quesada A, Zureik M, Rivera-Díaz R, Sahuquillo-Torralba A, Descalzo-Gallego MA, Lunt M, Garcia-Doval I, Sbidian E, Warren RB, Yiu ZZN. Phan DB, et al. Among authors: sahuquillo torralba a. BMJ Open. 2023 Jul 14;13(7):e075197. doi: 10.1136/bmjopen-2023-075197. BMJ Open. 2023. PMID: 37451726 Free PMC article.
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.
Sahuquillo-Torralba A, Hospital-Gil M, Vilarrasa-Rull E, Llamas-Velasco M, Rivera R, Carrascosa JM, de la Cueva-Dovao P, Armesto-Santos S, Ruíz-Villaverde R, Velasco-Pastor M, Magdaleno-Tapial J, Yanguas-Bayona JI, Ribera-Pibernat M, Salgado-Boquete L, Herranz-Pinto P, Romero-Mate A, Martínez-Lorenzo E, López-Estebaranz JL, Ballescá-López F, Botella-Estrada R. Sahuquillo-Torralba A, et al. Australas J Dermatol. 2023 Nov;64(4):e317-e326. doi: 10.1111/ajd.14130. Epub 2023 Jul 12. Australas J Dermatol. 2023. PMID: 37435962
[Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-α-Inhibitoren behandelten Patienten].
Palacios-Diaz RD, Sahuquillo-Torralba A, Rocamora-Durán V, Unamuno-Bustos B, Salavert-Lleti M, Santos-Alarcón S, Quintero A, Garcías-Ladaria J, Vila-Payeras A, Martínez-Doménech A, Mateu-Puchades A, Nadal-Lladó C, Botella-Estrada R. Palacios-Diaz RD, et al. Among authors: sahuquillo torralba a. J Dtsch Dermatol Ges. 2023 May;21(5):473-481. doi: 10.1111/ddg.15007_g. J Dtsch Dermatol Ges. 2023. PMID: 37183744 German.
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-α inhibitors.
Palacios-Diaz RD, Sahuquillo-Torralba A, Rocamora-Durán V, Unamuno-Bustos B, Salavert-Lleti M, Santos-Alarcón S, Quintero A, Garcías-Ladaria J, Vila-Payeras A, Martínez-Doménech A, Mateu-Puchades A, Nadal-Lladó C, Botella-Estrada R. Palacios-Diaz RD, et al. Among authors: sahuquillo torralba a. J Dtsch Dermatol Ges. 2023 May;21(5):473-480. doi: 10.1111/ddg.15007. Epub 2023 Apr 12. J Dtsch Dermatol Ges. 2023. PMID: 37042124
51 results